Jeffrey Jones
Chief Tech/Sci/R&D Officer presso CULLINAN THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Jeffrey Jones is currently the Chief Medical Officer at Cullinan Oncology, Inc. He previously worked as the Vice President-Global Drug Development & Lymphoma at Bristol Myers Squibb Co. from 2017 to 2022.
Prior to that, he was an Associate Professor at The Ohio State University College of Medicine and the Chief Medical Officer at Cullinan Oncology LLC.
Dr. Jones holds an MBA from Fisher College of Business, a doctorate from the University of Michigan Medical School, and a graduate degree from The University of Texas Health Science Center at Houston.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
22/02/2024 | 118 691 ( 0.28% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Jeffrey Jones
Società | Posizione | Inizio |
---|---|---|
CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 28/02/2022 |
Precedenti posizioni note di Jeffrey Jones
Società | Posizione | Fine |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 01/04/2020 |
The Ohio State University College of Medicine | Corporate Officer/Principal | - |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
Formazione di Jeffrey Jones
University of Michigan Medical School | Doctorate Degree |
The University of Texas Health Science Center at Houston | Graduate Degree |
Fisher College of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
CULLINAN THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Borsa valori
- Insiders
- Jeffrey Jones